Healthcare -
Biotechnology - NASDAQ - US
$ 12.29
-8.31 %
$ 1 B
Market Cap
-3.92
P/E
VRDN - REVENUE
Revenue VRDN - Viridian Therapeutics, Inc.
302 K
LAST VALUE
-58.72%
2 YEAR CAGR
-41.64%
5 YEAR CAGR
-23.36%
10 YEAR CAGR